Cytiva

Cytiva
source
Name	Cytiva
Type	Subsidiary
Industry	Biotechnology
Founded	2020 (brand established)
Predecessor	GE Healthcare Life Sciences
Headquarters	Marlborough, Massachusetts, U.S.
Area served	Global
Products	Bioprocessing equipment, consumables, instruments
Parent	Danaher Corporation

Cytiva is a global biotechnology company that provides technologies and services for the development and manufacture of biopharmaceuticals. The company supplies instruments, consumables, software, and support for biologics production used by organizations including Pfizer, Moderna, Roche, Novartis, and AstraZeneca. Cytiva serves clients across academic institutions such as Harvard University, Massachusetts Institute of Technology, and Stanford University, as well as contract development and manufacturing organizations like Lonza and WuXi Biologics.

History

Cytiva's roots trace to assets formerly part of GE Healthcare and earlier industrial lines connected to General Electric operations that interacted with entities including Amersham and Pharmacia. The rebranding to Cytiva followed acquisition by Danaher Corporation in 2020, a move within a corporate lineage involving transactions with firms such as GE Capital and corporations like Bain Capital in adjacent healthcare deals. Historically, technologies that became part of Cytiva were used in biomanufacturing projects at companies like Merck & Co., GlaxoSmithKline, and in collaborations with academic centers including Imperial College London and University of Cambridge.

Products and Technologies

Cytiva's portfolio includes chromatography media and systems used in protein purification by companies such as Bayer and Sanofi, single-use bioreactors employed by Biogen and Amgen, and filtration consumables adopted by Takeda and Bristol-Myers Squibb. Instruments are used alongside software platforms that integrate with laboratory information systems like those from Thermo Fisher Scientific and Agilent Technologies. Cytiva offers technologies that support workflows involving monoclonal antibodies manufactured for firms like Regeneron and cell and gene therapy processes pursued by Bluebird Bio and Sangamo Therapeutics.

Research and Development

Cytiva operates R&D programs that collaborate with universities such as Yale University, University of California, San Francisco, and Johns Hopkins University to innovate downstream purification methods and upstream cell culture technologies. The company participates in consortia and precompetitive collaborations with organizations like Bill & Melinda Gates Foundation and National Institutes of Health-funded initiatives, and engages with standards bodies such as the International Society for Pharmaceutical Engineering and European Medicines Agency stakeholders. Cytiva's R&D outputs are applied in regulatory submissions to agencies including the U.S. Food and Drug Administration and Medicines and Healthcare products Regulatory Agency.

Corporate Structure and Ownership

Cytiva is a subsidiary within the Danaher Corporation portfolio, operating alongside other Danaher subsidiaries such as Beckman Coulter Diagnostics and Leica Microsystems. Its governance reflects corporate practices influenced by interactions with investors like BlackRock and Vanguard Group through typical public-market ownership of its parent. Strategic decisions have been informed by executives with experience at firms including General Electric and Roche Diagnostics, and by advisory relationships involving consulting firms such as McKinsey & Company and Bain & Company.

Global Operations and Facilities

Cytiva maintains manufacturing and research sites in regions including North America, Europe, and Asia, with facilities linked to cities such as Marlborough, Massachusetts, Uppsala, Brussels, Shanghai, and operations proximate to hubs like Seattle, Basel, Cambridge (UK), and Singapore. The company supplies bioprocessing equipment to contract manufacturers including Catalent and Samsung Biologics and supports clinical manufacturing programs in collaboration with hospitals like Mayo Clinic and research institutes such as The Francis Crick Institute.

Partnerships and Collaborations

Cytiva has partnered with biotechnology and pharmaceutical companies including Moderna and Pfizer on supply chains for vaccine production, worked with contract development organizations like KBI Biopharma, and collaborated with academic entities such as Massachusetts General Hospital on translational projects. The company engages in technology alliances with instrument makers like GE Healthcare legacy teams and software integrators such as Siemens Healthineers and Dassault Systèmes for digital bioprocessing. Cytiva also participates in public–private efforts with organizations such as Coalition for Epidemic Preparedness Innovations and collaborates with philanthropic funders including Wellcome Trust.

Category:Biotechnology companies Category:Danaher subsidiaries